优化化和环化 pMDI 输送:式支室对吸入时间错误的保护作用
Leon L Csonka1, Lauri Lehtimäki1,2, Péter Csonka3,4
1Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
Journal of asthma and allergy
|September 3, 2025
概括
使用门保持室 (VHC) 与压力计量剂量吸入器 (pMDI) 显著改善药物输送,特别是吸入性皮质类固醇 (ICS),即使吸入时间不正确. 这一发现强调VHC对于有效治疗喘至关重要.
科学领域:
- 呼吸系统医学
- 药理学
- 生物医学工程
背景情况:
- 吸入器技术错误,特别是吸入器和压力计量剂量吸入器 (pMDI) 之间的失调,在吸入性皮质类固醇 (ICS) 中很常见.
- 这种协调问题可能会对治疗疗效产生负面影响.
- 据推测,当吸入延迟时,式保持室 (VHC) 可以改善ICS输送,但这种效果需要量化.
研究的目的:
- 在不同的吸入条件下量化VHCs对酸 (FP) 和酸 (CIC) 的空气动力学颗粒大小分布的影响.
- 在吸入时间不理想时,将药物输送效率与没有VHC进行比较.
主要方法:
- 使用下一代冲击器和成人喉模型研究FP和CIC的空气动力学颗粒大小分布.
- 使用呼吸模拟器产生标准成年人吸入.
- 测试了三个条件:在启动前吸入 (正确),在启动时吸入没有VHC,并在启动时吸入VHC.
主要成果:
- 与正确的技术相比,同时启动和吸入可显著降低FP和CIC的输送剂量.
- 使用同时激活的VHC大大改善了两种药物的输送剂量.
- 对于循环胺 (CIC),VHC的保护作用更为明显,使颗粒大小分数 (1-5μm和<1μm) 恢复到正确的吸入时间所见的水平.
结论:
- 使用pMDIs的低最佳吸入时间减少了ICS的产生,但VHC可以减轻这种影响.
- 在改善药物输送方面,VHC 具有显著的益处,特别是对于循环胺,即使在启动-吸入失调的情况下也是如此.
- 在临床验证之前,研究结果建议在儿童和成人群体中促进VHC的使用,以改善ICS治疗.
相关概念视频
01:23Inhaled Medications
388
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
388
01:26COPD: Management Using Bronchodilators and Corticosteroids
305
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
305
01:30Asthma-IV: Diagnostic and Management
2.6K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
383
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
383
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.7K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.7K
01:22Drug Delivery: Miscellaneous Routes
467
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
467